Ticker LaunchIPO · SMFL
Smart for Life, Inc.
Formerly Bonne Sante Group, Inc.
Smart for Life, Inc. (SMFL) priced its initial public offering on Feb 17, 2022 at $10.00 per share, within its $9.00–$11.00 range, raising $14.4M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $205.7M. Bevilacqua advised the company and Schiff Hardin advised the underwriters.
Smart for Life, Inc. is a global holding company developing, marketing, manufacturing and selling a broad range of nutritional products with an emphasis on health and wellness. It follows a buy-and-build strategy, acquiring companies and developing proprietary products.
- Status
- IPO
- Ticker
- SMFL
- Exchange
- Nasdaq Capital Market
- Priced
- Feb 17, 2022
- IPO price
- $10.00
- Price range
- $9.00–$11.00
- Raised
- $14.4M
- Market cap at IPO price
- $205.7M
- First filed
- Dec 16, 2021
- Company counsel
- Bevilacqua
- Underwriters' counsel
- Schiff Hardin
- Sector
- Biotech & pharma
- Country / state
- FL
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
- Analyst notes on the filing
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Dec 16, 2021
- Latest amendment Feb 11, 2022
- Final prospectus (424B4) Feb 17, 2022
- All filings on EDGAR CIK 1851860
Other Biotech & pharma IPOs in 2022
- Akanda Corp.AKAN · Mar 16, 2022
- Onconetix, Inc.BWV · Feb 23, 2022 · $20M
- TC BioPharm (Holdings) plcTCBP · Feb 14, 2022
- Nuvectis Pharma, Inc.NVCT · Feb 7, 2022
- Arcellx, Inc.ACLX · Feb 7, 2022 · $123.8M
- Amylyx Pharmaceuticals, Inc.AMLX · Jan 10, 2022 · $190M